EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseÜbersichtsarbeitOpen Access · CC BY 4.0

Metronidazole Susceptibility Patterns in European Bacteroides, Phocaeicola, and Parabacteroides Clinical Isolates—A Systematic Review and Meta-Analysis

Kinga Markowska-Michalak iD, Anna Majewska iD, Hanna Pituch iD

Medical Sciences · 24.07.2026 · 14 (4) · 424

DOI: 10.3390/medsci14040424 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Medical Sciences, online erschienen am 24.07.2026. Verfasst von Kinga Markowska-Michalak und 2 weiteren Autor:innen. Beteiligte Einrichtung: Chair and Department of Medical Microbiology, Medical University of Warsaw, Chalubinskiego 5 Street., 02-004 Warsaw, Poland. Hauptthemen laut MEDLINE: Metronidazole, Bacteroides, Anti-Bacterial Agents. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This study aimed to provide an updated overview of metronidazole susceptibility among human clinical isolates of Bacteroides, Phocaeicola, and Parabacteroides in Europe based on EUCAST breakpoint interpretation.

Methods

A systematic review and meta-analysis were undertaken following searches of Web of Science, MEDLINE/PubMed, and Embase for studies published between 2011 and 2025. Eligible studies reported metronidazole susceptibility data, including minimum inhibitory concentrations and/or susceptible/resistant proportions, for clinical isolates from European countries. Risk of bias was assessed using criteria adapted from the Joanna Briggs Institute critical appraisal tool. Random-effects meta-analysis of proportions was used to estimate pooled susceptibility, with heterogeneity quantified by I2 and τ2; 95% prediction intervals and country subgroup analyses were also performed. Small-study effects were evaluated by funnel plot inspection, Egger’s and Begg’s tests.

Results

Thirty-eight studies, comprising 72 country-specific datasets and 8501 isolates, were included. The pooled susceptibility proportion was 99.81% (95% CI 99.44–99.99%), with substantial heterogeneity (I2 = 68.2%; τ2 = 0.0038). The 95% prediction interval ranged from 95.75% to 100%. Although between-country differences were statistically significant, susceptibility remained consistently high overall. Lower values in Portugal and Switzerland came from single small datasets.

Conclusions

These findings support the sustained in vitro activity of metronidazole across Europe, while highlighting the need for continued surveillance, particularly in underrepresented settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetronidazoleBacteroidesAnti-Bacterial AgentsHumansEuropeMicrobial Sensitivity TestsDrug Resistance, Bacterial

Stichwörter der Autor:innen

BacteroidesParabacteroidesPhocaeicolaanaerobic bacteriaantimicrobial resistancemetronidazole

Substanzen

MetronidazoleAnti-Bacterial Agents

Autor:innen und Institutionen

  • Chair and Department of Medical Microbiology, Medical University of Warsaw, Chalubinskiego 5 Street., 02-004 Warsaw, Poland.

ORCID-Profile: Kinga Markowska-Michalak, Anna Majewska, Hanna Pituch

Zitieren

APA

Markowska-Michalak, K., Majewska, A., & Pituch, H. (2026). Metronidazole Susceptibility Patterns in European Bacteroides, Phocaeicola, and Parabacteroides Clinical Isolates—A Systematic Review and Meta-Analysis. Medical Sciences, 14(4), 424. https://doi.org/10.3390/medsci14040424

Vancouver

Markowska-Michalak K, Majewska A, Pituch H. Metronidazole Susceptibility Patterns in European Bacteroides, Phocaeicola, and Parabacteroides Clinical Isolates—A Systematic Review and Meta-Analysis. Medical Sciences. 2026;14(4):424. doi:10.3390/medsci14040424

BibTeX
@article{MarkowskaMichalak2026,
  author = {Markowska-Michalak, Kinga and Majewska, Anna and Pituch, Hanna},
  title = {Metronidazole Susceptibility Patterns in European Bacteroides, Phocaeicola, and Parabacteroides Clinical Isolates—A Systematic Review and Meta-Analysis},
  journal = {Medical Sciences},
  year = {2026},
  volume = {14},
  number = {4},
  pages = {424},
  doi = {10.3390/medsci14040424}
}
Kostenlos starten →